Glaukos

Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. The Aliso Viejo property will serve as Glaukos’s new corporate headquarters and will house admin, R&D, and lab space. The property was built in 1999 and renovated in 2020. The property is 100% leased to Glaukos Corporation and is currently undergoing an extensive renovation to accommodate the Company's new corporate HQ.